Multi-Gene Hereditary Cancer Panel Testing
Comprehensive 30+ gene hereditary cancer risk assessment for you and your family across India.
Hereditary cancer panel testing analyzes 30+ genes — including BRCA1/2, Lynch syndrome genes, ATM, PALB2, CHEK2, and more — to give a complete picture of inherited cancer risk across multiple cancer types.
Multi-Gene Hereditary Cancer Panel Testing
Comprehensive 30+ gene hereditary cancer risk assessment for you and your family across India.
Hereditary cancer panel testing analyzes 30+ genes — including BRCA1/2, Lynch syndrome genes, ATM, PALB2, CHEK2, and more — to give a complete picture of inherited cancer risk across multiple cancer types.
500+
Genes Analyzed
24hr
Expert Callback
95%
Clinical Actionability
What is a Hereditary Cancer Panel?
A hereditary cancer panel simultaneously analyzes 30 or more genes associated with inherited cancer risk — from a single blood or saliva sample. Rather than testing one gene at a time, this multi-gene germline panel provides a complete picture of inherited risk across multiple cancer types in one comprehensive result. It is the most efficient and clinically thorough option for individuals with a personal or family history of cancer.
A hereditary cancer panel goes well beyond BRCA testing. Genes like PALB2, ATM, CHEK2, CDH1, and Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2) carry clinically significant cancer risk that would be missed in a BRCA-only test. For patients across India with a strong family cancer history — especially multiple relatives or early-onset cancers — a 30+ gene panel is typically recommended over single-gene testing. BigOHealth coordinates multi-gene panel testing with certified genetic counselors who guide you through pre-test counseling, result interpretation, and long-term family surveillance planning.
Quick Facts
30+
Genes Screened
Blood or Saliva
Sample Needed
14–28 Days
Report Time
Breast, Colon, Ovarian & More
Cancers Covered
What Hereditary Cancer Panel Can Detect
A single panel screens for every major class of cancer-driving genetic alteration.
BRCA1/2
Hereditary breast, ovarian, pancreatic, and prostate cancer risk — the most clinically significant hereditary cancer genes
Lynch Syndrome Genes
MLH1, MSH2, MSH6, PMS2, EPCAM — inherited colorectal, endometrial, and ovarian cancer risk
ATM / PALB2
Moderate-to-high risk genes for breast and pancreatic cancer — often missed in BRCA-only testing
CHEK2, CDH1 & Others
30+ additional cancer-predisposition genes covering gastric, thyroid, melanoma, and other cancer risks
Book Hereditary Cancer Panel Testing
Comprehensive 30+ gene inherited cancer risk assessment with certified genetic counselor support
No obligation. Free consultation included.
How long does hereditary cancer panel testing take?
Sample Collection
Blood or saliva sample collected at a clinic or via home visit in India
DNA Extraction & QC
Germline DNA isolated and quality-checked before 30+ gene sequencing begins
Panel Sequencing & Classification
All 30+ genes fully sequenced; every variant classified per ACMG standards
Report & Counseling Session
Certified genetic counselor delivers findings with personalized family and surveillance guidance
Total turnaround: 14–28 business days from sample collection to final report. Our team calls back within 24 hours of your enquiry to guide you through the process.
Hereditary Cancer Panel Cost in India
Transparent multi-gene panel pricing in India — from core panels to the full 30+ gene comprehensive test.
Starting Prices
Compare Test Prices
Indicative starting prices for common genomics test options.
What's Included
Core Panel (10–15 genes)
Covers the most common hereditary cancer genes
₹20,000+
onwards
Exact hereditary cancer panel cost in India depends on gene count, lab, and whether family cascade testing is added. Contact us for a personalized quote.
Why Hereditary Cancer Panel Matters
Inherited mutations don't just affect you — they run through families. A 30+ gene panel finds the one mutation that can guide surveillance, prevention, and family cascade testing for an entire generation.
1 in 8
individuals with a strong family cancer history carry an actionable hereditary mutation
30+
cancer-predisposition genes analyzed in a single panel
5–10×
lifetime cancer risk reduction possible with surveillance in confirmed carriers
Find mutations BRCA-only testing misses
Genes like PALB2, ATM, CHEK2, CDH1, and Lynch syndrome genes carry clinically significant cancer risk — but are completely missed in a BRCA-only test. A 30+ panel leaves no gene unchecked.
Detect hereditary syndromes early
Lynch syndrome (MLH1, MSH2, MSH6, PMS2) raises lifetime colorectal and endometrial cancer risk dramatically — but is manageable with early, targeted surveillance. A panel identifies it before any tumor develops.
Protect your family with cascade testing
Once a pathogenic variant is confirmed, first-degree relatives can test for that specific mutation at a fraction of the cost — turning one result into family-wide protection.
Guide prevention, not just treatment
Carriers can choose enhanced MRI and colonoscopy surveillance, chemoprevention, or prophylactic surgery based on the specific gene and mutation found — not population-average risk tables.
Influence treatment if cancer is already present
BRCA1/2 carrier status qualifies for PARP inhibitors. Lynch syndrome affects immunotherapy eligibility. Germline data from a panel directly changes which therapies your oncologist will choose.
Got your report? We'll walk you through it.
What will your hereditary cancer panel result say?
A multi-gene hereditary panel report classifies every detected variant across all 30+ genes. The classification determines whether — and how — you and your family need to act.
Pathogenic / Likely Pathogenic
A disease-causing mutation confirmed in one or more genes. Clinical surveillance, family cascade testing, and prevention planning are recommended immediately.
Negative
No pathogenic mutations detected across all tested genes. Residual population-level risk still exists, especially with strong family history — discuss ongoing surveillance with your doctor.
Variant of Unknown Significance (VUS)
A variant was found whose clinical significance is still being studied. Not currently actionable, but tracked for reclassification as evidence grows.
Multiple Gene Findings
Some patients carry mutations in more than one cancer-predisposition gene — each finding is assessed independently for clinical significance and surveillance implications.
Second Opinion on Your Hereditary Cancer Panel Report
Got a VUS or pathogenic variant on your hereditary cancer panel and unsure what it means for you and your family? Our genetic counselors in India review your multi-gene panel results — covering BRCA1/2, Lynch syndrome, PALB2, CHEK2, and more — and help you build a personalised surveillance and prevention plan.
What our experts review
Why patients trust us
- Reviewed by certified molecular oncologists
- Response within 2 business hours
- 100% confidential — your data stays private
Not sure what your Hereditary Cancer Panel report means?
Benefits of Hereditary Cancer Panel
Every benefit below translates into a more informed, faster, and more personal treatment decision.
Comprehensive Risk Picture
30+ cancer genes analyzed in one test — BRCA1/2, Lynch syndrome, ATM, PALB2, CHEK2, CDH1, and more
Family Protection
Identify inherited mutations that may affect your children, siblings, and parents — one result guides an entire family
Personalized Surveillance
Move from population screening to mutation-specific surveillance intervals and imaging protocols
Prevention Guidance
Make informed decisions about risk-reduction surgery, chemoprevention, or enhanced screening based on your actual gene
Treatment Optimization
Germline carrier status directly influences therapy selection — PARP inhibitors, immunotherapy eligibility, and more
One Comprehensive Test
A single panel covers your complete inherited cancer risk — no need to retest as recommendations evolve
See exactly which of these benefits apply to your case.
Genetic Counseling Is Essential for Hereditary Panel Testing
Multi-gene panel results are complex. A certified genetic counselor ensures you and your family fully understand every finding.
Pre-test Education
Understand the scope, limitations, and implications of panel testing before you proceed — including what a VUS result means
Comprehensive Result Review
Navigate findings across all 30+ genes with gene-by-gene explanations and personalized risk assessment
Cascade Family Testing
Identify which relatives should be tested and coordinate the process — usually a faster, lower-cost targeted test
Long-term Surveillance Plan
Build a personalized screening and prevention roadmap based on your specific gene and mutation found
Frequently Asked Questions
Answers for both first-time patients and those who already have a Hereditary Cancer Panel report in hand.
A hereditary cancer panel simultaneously analyzes 30+ genes associated with inherited cancer risk — including BRCA1/2, Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2), ATM, PALB2, CHEK2, and more. It provides a comprehensive view of inherited risk across multiple cancer types.
Hereditary cancer panel testing is recommended for: individuals with a strong personal or family history of cancer, early-onset cancers (before age 50), multiple primary cancers, rare cancers linked to hereditary syndromes, or when a family member has a known hereditary cancer mutation.
For most patients with a significant cancer family history, a multi-gene panel is more informative than BRCA testing alone. It tests all major hereditary cancer genes at once, reducing cost and turnaround time compared to sequential single-gene testing.
Lynch syndrome is the most common hereditary colorectal and endometrial cancer syndrome, caused by mutations in MLH1, MSH2, MSH6, or PMS2 genes. Yes, our hereditary cancer panel includes all Lynch syndrome genes alongside BRCA1/2 and 25+ other cancer risk genes.
A Variant of Uncertain Significance (VUS) means a gene change was detected where the clinical significance is not yet established. Most VUSes are eventually reclassified as benign. A genetic counselor will explain monitoring plans and what to watch for as evidence evolves.
Hereditary cancer panel results are typically available in 14–28 business days. The extended timeline reflects the comprehensive scope of 30+ genes being analyzed. Results are delivered with a genetic counseling session.
Yes. If you test positive for a pathogenic mutation, first-degree relatives (parents, siblings, children) have a 50% chance of carrying the same mutation. Cascade testing helps family members make informed decisions about early surveillance and preventive measures.
India currently has limited genetic non-discrimination laws. Discuss insurance implications with your genetic counselor before testing if this is a concern. However, early detection through hereditary testing typically saves significant future healthcare costs.
Still have questions about your Hereditary Cancer Panel report or results?
Other Genomic Tests You May Need
Hereditary Cancer Panel Applies Across Cancer Types
Not sure which test applies to you?
Get a second opinion or consult our multidisciplinary tumor board to confirm the right genomic test for your diagnosis.
Know Your Family's Inherited Cancer Risk
Whether you're considering testing, reviewing a panel report, or unsure which genes matter — our genetic counselors are one tap away.
